Low prevalence of apolipoprotein E ε4 allele in the neurofibrillary tangle predominant form of senile dementia

[1]  G. Getz,et al.  Association of human, rat, and rabbit apolipoprotein E with β‐amyloid , 1997, Journal of neuroscience research.

[2]  T. Lehtimäki,et al.  Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains , 1997, Neurobiology of Aging.

[3]  H. Akiyama,et al.  605 Senile dementia with abundant neurofibrillary tangles without accompanying senile plaques. A new disease entity separable from SDAT? , 1996, Neurobiology of Aging.

[4]  K. Blennow,et al.  The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[5]  E. Otomo,et al.  Apolipoprotein E genotype in elderly nondemented subjects without senile changes in the brain , 1996, Annals of neurology.

[6]  K. Jellinger,et al.  On the relationship between measles virus and Alzheimer neurofibrillary tangles in subacute sclerosing panencephalitis , 1996, Neurobiology of Aging.

[7]  L. Thal,et al.  The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant , 1996, Neurology.

[8]  R. Crowther,et al.  Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles , 1996, Acta Neuropathologica.

[9]  D. Sparks,et al.  Increased density of senile plaques (SP), but not neurofibrillary tangles (NFT), in non-demented individuals with the apolipoprotein E4 allele: comparison to confirmed Alzheimer's disease patients , 1996, Journal of the Neurological Sciences.

[10]  R. Defendini,et al.  The neuropathology of chromosome 17‐linked dementia , 1996, Annals of neurology.

[11]  T. Kinoshita,et al.  Apolipoprotein E allele in centenarians , 1996, Neurology.

[12]  K. Manton,et al.  Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. , 1996, Archives of neurology.

[13]  G. Schellenberg,et al.  Normal distribution of apolipoprotein E alleles in progressive supranuclear palsy , 1996, Neurology.

[14]  W. Tsai,et al.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. , 1996, American journal of human genetics.

[15]  C. Soto,et al.  Alzheimer's β‐amyloid peptide is conformationally modified by apolipoprotein E in vitro , 1996, Neuroreport.

[16]  D. Pollen,et al.  Familial and sporadic Alzheimer's disease , 1996, Neurology.

[17]  J. Wegiel,et al.  Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines * , 1996, Neuropathology and applied neurobiology.

[18]  J. Geddes,et al.  Neurofibrillary tangles, but not Alzheimer‐type pathology, in a young boxer , 1996, Neuropathology and applied neurobiology.

[19]  W. März,et al.  Apolipoprotein E Polymorphism Is Associated with Both Senile Plaque Load and Alzheimer‐Type Neurofibrillary Tangle Formation a , 1996, Annals of the New York Academy of Sciences.

[20]  B T Hyman,et al.  Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease , 1996, Annals of neurology.

[21]  A. Smith,et al.  Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease , 1995, Neuroscience.

[22]  C. Morris,et al.  Effect of apolipoprotein E genotype on Alzheimer's disease neuropathology in a cohort of elderly Norwegians , 1995, Neuroscience Letters.

[23]  I. McKeith,et al.  Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[24]  K Kontula,et al.  Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. , 1995, The New England journal of medicine.

[25]  H C Hendrie,et al.  Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. , 1995, The American journal of psychiatry.

[26]  M. Tabaton,et al.  Apolipoprotein E element 4 allele frequency is not increased in progressive supranuclear palsy , 1995, Neurology.

[27]  D. Mann,et al.  The extent of amyloid deposition in brain in patients with Down's syndrome does not depend upon the apolipoprotein E genotype , 1995, Neuroscience Letters.

[28]  R. Martins,et al.  ApoE genotypes in Australia: roles in early and late onset Alzheimer's disease and Down's syndrome , 1995, Neuroreport.

[29]  W. März,et al.  Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation , 1995, Neuroscience.

[30]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele ϵ4 with late‐onset Alzheimer's disease among Finnish centenarians , 1995, Neurology.

[31]  R. Mantegna,et al.  Quantitative analysis of senile plaques in Alzheimer disease: observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[33]  B. Tycko,et al.  Apolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks , 1995, Annals of neurology.

[34]  S. Gauthier,et al.  Predictive value of apolipoprotein E genotyping in Alzheimer's disease: Results of an autopsy series and an analysis of several combined studies , 1994, Annals of neurology.

[35]  E. Perry,et al.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. , 1994, The American journal of pathology.

[36]  D. Galasko,et al.  Apolipoprotein-E ε-4 is associated with increased neurofibrillary pathology in the Lewy body variant of Alzheimer's disease , 1994, Neuroscience Letters.

[37]  H. Brewer,et al.  Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.

[38]  I Litvan,et al.  Preliminary NINDS neuropathologic criteria for Steele‐Richardson‐Olszewski syndrome (progressive supranuclear palsy) , 1994, Neurology.

[39]  Bradley T. Hyman,et al.  Reduced apolipoprotein ϵ4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals , 1994, Neurology.

[40]  J. Hardy,et al.  APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease , 1994, Neuroscience Letters.

[41]  P. Amouyel,et al.  Confirmation of the ϵ4 allele of the apolipoprotein E gene as a risk factor for late‐onset Alzheimer's disease , 1994, Neurology.

[42]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[43]  B. Hyman,et al.  Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions , 1993, Neuron.

[44]  S. Gauthier,et al.  Apolipoprotein E polymorphism and Alzheimer's disease , 1993, The Lancet.

[45]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[46]  A. D. Roses,et al.  Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .

[47]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. Mirra,et al.  Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. , 1993, Archives of pathology & laboratory medicine.

[49]  S. M. Sumi,et al.  Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala , 1992, Neurology.

[50]  W. Snow,et al.  The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease , 1988, Neurology.

[51]  C. Filley.  Diagnosis of Alzheimer's disease. , 1988, Colorado medicine.

[52]  R. Katzman.,et al.  Senile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles , 1987, Journal of neuropathology and experimental neurology.

[53]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[54]  H. Wiśniewski,et al.  Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia , 1979, Annals of neurology.

[55]  B. Dastugue,et al.  [Apolipoprotein E and Alzheimer's disease]. , 1998, Annales de biologie clinique.

[56]  M. Tabaton,et al.  Apolipoprotein E epsilon 4 allele frequency is not increased in progressive supranuclear palsy. , 1995, Neurology.

[57]  R. Sulkava,et al.  Lack of association of apolipoprotein E allele epsilon 4 with late-onset Alzheimer's disease among Finnish centenarians. , 1995, Neurology.

[58]  L Carlin,et al.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. , 1995, Archives of neurology.

[59]  L. Middleton,et al.  Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprus , 1995, Genetic epidemiology.

[60]  B T Hyman,et al.  Reduced apolipoprotein epsilon 4 allele frequency in the oldest old Alzheimer's patients and cognitively normal individuals. , 1994, Neurology.

[61]  P. Froguel,et al.  Genetic associations with human longevity at the APOE and ACE loci , 1994, Nature Genetics.

[62]  J. Ulrich.  Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia , 1992 .

[63]  C. Sing,et al.  Apolipoprotein E polymorphism and atherosclerosis. , 1988, Arteriosclerosis.

[64]  W. Snow,et al.  The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimerʼs disease: a clinicopathologic study of 57 cases , 1988 .